Agmatine

References

1. ^ Naila A, et al. Control of biogenic amines in food–existing and emerging approaches. J Food Sci. (2010)
2. ^ a b c Molderings GJ, Haenisch B. Agmatine (decarboxylated L-arginine): physiological role and therapeutic potential. Pharmacol Ther. (2012)
3. ^ a b Holt A, Baker GB. Metabolism of agmatine (clonidine-displacing substance) by diamine oxidase and the possible implications for studies of imidazoline receptors. Prog Brain Res. (1995)
4. ^ Galgano F, et al. Focused review: agmatine in fermented foods. Front Microbiol. (2012)
5. ^ Authentication of Italian red wines on the basis of the polyphenols and biogenic amines.
6. ^ HPLC determination of agmatine and other amines in wine.
7. ^ De Borba BM, Rohrer JS. Determination of biogenic amines in alcoholic beverages by ion chromatography with suppressed conductivity detection and integrated pulsed amperometric detection. J Chromatogr A. (2007)
8. ^ The biogenic amine content of beer; the effect of barley, malting and brewing on amine concentration.
9. ^ Kvasnicka F, Voldrich M. Determination of biogenic amines by capillary zone electrophoresis with conductometric detection. J Chromatogr A. (2006)
10. ^ Okamoto A, et al. Polyamine content of ordinary foodstuffs and various fermented foods. Biosci Biotechnol Biochem. (1997)
11. ^ Profile and levels of bioactive amines in instant coffee.
12. ^ Ruiz-Capillas C, Jiménez-Colmenero F. Biogenic amines in meat and meat products. Crit Rev Food Sci Nutr. (2004)
13. ^ Lorenzo JM, et al. Biogenic amine content during the manufacture of dry-cured lacón, a Spanish traditional meat product: Effect of some additives. Meat Sci. (2007)
14. ^ Bover-Cid S, Izquierdo-Pulido M, Carmen Vidal-Carou M. Changes in biogenic amine and polyamine contents in slightly fermented sausages manufactured with and without sugar. Meat Sci. (2001)
15. ^ Consequences of high-pressure processing of vacuum-packaged frankfurters on the formation of polyamines: Effect of chilled storage.
16. ^ Biogenic amine changes in barramundi (Lates calcarifer) slices stored at 0 °C and 4 °C.
17. ^ Ruiz-Capillas C, Moral A. Free amino acids and biogenic amines in red and white muscle of tuna stored in controlled atmospheres. Amino Acids. (2004)
18. ^ Quality changes of anchovy (Stolephorus heterolobus) under refrigerated storage of different practical industrial methods in Thailand.
19. ^ Profile and levels of bioactive amines in green and roasted coffee.
20. ^ Monitoring of biologically active amines in cereals and cereal based food products by HPLC.
21. ^ Kirschbaum J, Rebscher K, Brückner H. Liquid chromatographic determination of biogenic amines in fermented foods after derivatization with 3,5-dinitrobenzoyl chloride. J Chromatogr A. (2000)
22. ^ Gründemann D, et al. Agmatine is efficiently transported by non-neuronal monoamine transporters extraneuronal monoamine transporter (EMT) and organic cation transporter 2 (OCT2). J Pharmacol Exp Ther. (2003)
23. ^ a b c Steer H. The source of carbon dioxide for gastric acid production. Anat Rec (Hoboken). (2009)
24. ^ a b Jones TZ, et al. Interactions of imidazoline ligands with the active site of purified monoamine oxidase A. FEBS J. (2007)
25. ^ a b Remko M, Swart M, Bickelhaupt FM. Theoretical study of structure, pKa, lipophilicity, solubility, absorption, and polar surface area of some centrally acting antihypertensives. Bioorg Med Chem. (2006)
26. ^ Zhu MY, et al. Expression of human arginine decarboxylase, the biosynthetic enzyme for agmatine. Biochim Biophys Acta. (2004)
27. ^ a b c d Raasch W, et al. Agmatine is widely and unequally distributed in rat organs. Ann N Y Acad Sci. (1995)
28. ^ a b c d e Raasch W, et al. Agmatine, the bacterial amine, is widely distributed in mammalian tissues. Life Sci. (1995)
29. ^ Iyer RK, et al. Cloning and characterization of human agmatinase. Mol Genet Metab. (2002)
30. ^ Mistry SK, et al. Cloning of human agmatinase. An alternate path for polyamine synthesis induced in liver by hepatitis B virus. Am J Physiol Gastrointest Liver Physiol. (2002)
31. ^ Haenisch B, et al. Regulatory mechanisms underlying agmatine homeostasis in humans. Am J Physiol Gastrointest Liver Physiol. (2008)
32. ^ Dallmann K, et al. Human agmatinase is diminished in the clear cell type of renal cell carcinoma. Int J Cancer. (2004)
33. ^ a b c Bernstein HG, et al. Agmatinase, an inactivator of the putative endogenous antidepressant agmatine, is strongly upregulated in hippocampal interneurons of subjects with mood disorders. Neuropharmacology. (2012)
34. ^ a b Sastre M, et al. Metabolism of agmatine in macrophages: modulation by lipopolysaccharide and inhibitory cytokines. Biochem J. (1998)
35. ^ Haenisch B, et al. Effects of exogenous agmatine in human leukemia HMC-1 and HL-60 cells on proliferation, polyamine metabolism and cell cycle. Leuk Res. (2011)
36. ^ Regunathan S, et al. Imidazoline receptors and agmatine in blood vessels: a novel system inhibiting vascular smooth muscle proliferation. J Pharmacol Exp Ther. (1996)
37. ^ Gorbatyuk OS, et al. Localization of agmatine in vasopressin and oxytocin neurons of the rat hypothalamic paraventricular and supraoptic nuclei. Exp Neurol. (2001)
38. ^ a b c Reis DJ, Yang XC, Milner TA. Agmatine containing axon terminals in rat hippocampus form synapses on pyramidal cells. Neurosci Lett. (1998)
39. ^ a b c d e f Otake K, et al. Regional localization of agmatine in the rat brain: an immunocytochemical study. Brain Res. (1998)
40. ^ Imidazoline Receptors and Their Endogenous Ligands.
41. ^ Wang H, et al. An antibody to agmatine localizes the amine in bovine adrenal chromaffin cells. Neurosci Lett. (1995)
42. ^ a b Molderings GJ, et al. Gastrointestinal uptake of agmatine: distribution in tissues and organs and pathophysiologic relevance. Ann N Y Acad Sci. (2003)
43. ^ a b c Gilad GM, et al. Metabolism of agmatine into urea but not into nitric oxide in rat brain. Neuroreport. (1996)
44. ^ a b Komori Y, Wallace GC, Fukuto JM. Inhibition of purified nitric oxide synthase from rat cerebellum and macrophage by L-arginine analogs. Arch Biochem Biophys. (1994)
45. ^ a b Yokoi I, et al. Structure-activity relationships of arginine analogues on nitric oxide synthase activity in the rat brain. Neuropharmacology. (1994)
46. ^ a b Sennequier N, Stuehr DJ. Analysis of substrate-induced electronic, catalytic, and structural changes in inducible NO synthase. Biochemistry. (1996)
47. ^ a b c Novotny WF, et al. Diamine oxidase is the amiloride-binding protein and is inhibited by amiloride analogues. J Biol Chem. (1994)
48. ^ McGrath AP, et al. A new crystal form of human diamine oxidase. Acta Crystallogr Sect F Struct Biol Cryst Commun. (2010)
49. ^ a b c d e f Cabella C, et al. Transport and metabolism of agmatine in rat hepatocyte cultures. Eur J Biochem. (2001)
50. ^ a b Mella C, et al. Expression and localization of an agmatinase-like protein in the rat brain. Histochem Cell Biol. (2010)
51. ^ Polo LM, et al. New insight into the transcarbamylase family: the structure of putrescine transcarbamylase, a key catalyst for fermentative utilization of agmatine. PLoS One. (2012)
52. ^ a b Satriano J, et al. Agmatine suppresses proliferation by frameshift induction of antizyme and attenuation of cellular polyamine levels. J Biol Chem. (1998)
53. ^ Babál P, et al. Regulation of ornithine decarboxylase activity and polyamine transport by agmatine in rat pulmonary artery endothelial cells. J Pharmacol Exp Ther. (2001)
54. ^ Satriano J, Kelly CJ, Blantz RC. An emerging role for agmatine. Kidney Int. (1999)
55. ^ Llácer JL, et al. The gene cluster for agmatine catabolism of Enterococcus faecalis: study of recombinant putrescine transcarbamylase and agmatine deiminase and a snapshot of agmatine deiminase catalyzing its reaction. J Bacteriol. (2007)
56. ^ Wargnies B, Lauwers N, Stalon V. Structure and properties of the putrescine carbamoyltransferase of Streptococcus faecalis. Eur J Biochem. (1979)
57. ^ Simon JP, Stalon V. Enzymes of agmatine degradation and the control of their synthesis in Streptococcus faecalis. J Bacteriol. (1982)
58. ^ Biosynthesis and metabolism of arginine in bacteria.
59. ^ Simon JP, Wargnies B, Stalon V. Control of enzyme synthesis in the arginine deiminase pathway of Streptococcus faecalis. J Bacteriol. (1982)
60. ^ Xi H, Schneider BL, Reitzer L. Purine catabolism in Escherichia coli and function of xanthine dehydrogenase in purine salvage. J Bacteriol. (2000)
61. ^ TIGIER H, GRISOLIA S. INDUCTION OF CARBAMYL-P SPECIFIC OXAMATE TRANSCARBAMYLASE BY PARABANIC ACID IN A STREPTOCOCCUS. Biochem Biophys Res Commun. (1965)
62. ^ a b c d e f Aricioglu F, Regunathan S, Piletz JE. Is agmatine an endogenous factor against stress. Ann N Y Acad Sci. (2003)
63. ^ a b c d Piletz JE, et al. Agmatine crosses the blood-brain barrier. Ann N Y Acad Sci. (2003)
64. ^ a b c Feng Y, Halaris AE, Piletz JE. Determination of agmatine in brain and plasma using high-performance liquid chromatography with fluorescence detection. J Chromatogr B Biomed Sci Appl. (1997)
65. ^ a b c Regunathan S, et al. Agmatine levels in the cerebrospinal fluid of normal human volunteers. J Pain Palliat Care Pharmacother. (2009)
66. ^ a b Jo I, et al. Low levels of plasma agmatine in the metabolic syndrome. Metab Syndr Relat Disord. (2010)
67. ^ a b c d e f g h i j k l m Li G, et al. Agmatine: an endogenous clonidine-displacing substance in the brain. Science. (1994)
68. ^ a b Uzbay T, et al. Increased plasma agmatine levels in patients with schizophrenia. J Psychiatr Res. (2013)
69. ^ a b c Halaris A, et al. Plasma agmatine and platelet imidazoline receptors in depression. Ann N Y Acad Sci. (1999)
70. ^ a b c d Molderings GJ, et al. Exposure of rat isolated stomach and rats in vivo to {(14)C}agmatine: accumulation in the stomach wall and distribution in various tissues. Fundam Clin Pharmacol. (2002)
71. ^ a b c d e f g h i Li YF, et al. Antidepressant-like effect of agmatine and its possible mechanism. Eur J Pharmacol. (2003)
72. ^ a b c d Roberts JC, et al. Pharmacodynamic and pharmacokinetic studies of agmatine after spinal administration in the mouse. J Pharmacol Exp Ther. (2005)
73. ^ a b c Raasch W, et al. Agmatine, an endogenous ligand at imidazoline binding sites, does not antagonize the clonidine-mediated blood pressure reaction. Br J Pharmacol. (2002)
74. ^ a b Satriano J, et al. Polyamine transport system mediates agmatine transport in mammalian cells. Am J Physiol Cell Physiol. (2001)
75. ^ a b Agmatine Is Efficiently Transported by Non-Neuronal Monoamine Transporters Extraneuronal Monoamine Transporter (EMT) and Organic Cation Transporter 2 (OCT2).
76. ^ Agmatine Is Synthesized by a Mitochondrial Arginine Decarboxylase in Rat Brain.
77. ^ Endogenous pain modulation: Neuropharmacokinetic/dynamic studies of the endogenous NMDA receptor antagonist/NOS inhibitor, agmatine.
78. ^ Reis DJ, Regunathan S. Agmatine: a novel neurotransmitter. Adv Pharmacol. (1998)
79. ^ Sastre M, et al. Agmatinase activity in rat brain: a metabolic pathway for the degradation of agmatine. J Neurochem. (1996)
80. ^ a b c Goracke-Postle CJ, et al. Release of tritiated agmatine from spinal synaptosomes. Neuroreport. (2006)
81. ^ Sastre M, Regunathan S, Reis DJ. Uptake of agmatine into rat brain synaptosomes: possible role of cation channels. J Neurochem. (1997)
82. ^ Goracke-Postle CJ, et al. Potassium- and capsaicin-induced release of agmatine from spinal nerve terminals. J Neurochem. (2007)
83. ^ a b Goracke-Postle CJ, et al. Agmatine transport into spinal nerve terminals is modulated by polyamine analogs. J Neurochem. (2007)
84. ^ Regunathan S, et al. Agmatine (decarboxylated arginine) is synthesized and stored in astrocytes. Neuroreport. (1995)
85. ^ a b Zomkowski AD, Santos AR, Rodrigues AL. Putrescine produces antidepressant-like effects in the forced swimming test and in the tail suspension test in mice. Prog Neuropsychopharmacol Biol Psychiatry. (2006)
86. ^ a b c d e Molderings GJ, et al. Dual interaction of agmatine with the rat alpha(2D)-adrenoceptor: competitive antagonism and allosteric activation. Br J Pharmacol. (2000)
87. ^ a b c d e f g h Dias Elpo Zomkowski A, et al. Evidence for serotonin receptor subtypes involvement in agmatine antidepressant like-effect in the mouse forced swimming test. Brain Res. (2004)
88. ^ a b c d Gibson DA, et al. Radioligand binding studies reveal agmatine is a more selective antagonist for a polyamine-site on the NMDA receptor than arcaine or ifenprodil. Brain Res. (2002)
89. ^ Lewin AH, et al. Molecular features associated with polyamine modulation of NMDA receptors. J Med Chem. (1998)
90. ^ a b c d e f g h i j k Jiang XZ, et al. 5-HT1A/1B receptors, alpha2-adrenoceptors and the post-receptor adenylate cyclase activation in the mice brain are involved in the antidepressant-like action of agmatine. Yao Xue Xue Bao. (2008)
91. ^ a b Piletz JE, Chikkala DN, Ernsberger P. Comparison of the properties of agmatine and endogenous clonidine-displacing substance at imidazoline and alpha-2 adrenergic receptors. J Pharmacol Exp Ther. (1995)
92. ^ a b c Morrissey JJ, Klahr S. Agmatine activation of nitric oxide synthase in endothelial cells. Proc Assoc Am Physicians. (1997)
93. ^ a b c d e f Chang CH, et al. Increase of beta-endorphin secretion by agmatine is induced by activation of imidazoline I(2A) receptors in adrenal gland of rats. Neurosci Lett. (2010)
94. ^ a b Pinthong D, et al. Comparison of the interaction of agmatine and crude methanolic extracts of bovine lung and brain with alpha 2-adrenoceptor binding sites. Br J Pharmacol. (1995)
95. ^ a b c Pinthong D, et al. Agmatine recognizes alpha 2-adrenoceptor binding sites but neither activates nor inhibits alpha 2-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol. (1995)
96. ^ Pinthong D, et al. No evidence for activation of alpha(2)-adrenoceptors by methanolic extracts of bovine brain and lung containing clonidine-displacing substance. Ann N Y Acad Sci. (2003)
97. ^ a b c d Taksande BG, et al. Agmatine in the hypothalamic paraventricular nucleus stimulates feeding in rats: involvement of neuropeptide Y. Br J Pharmacol. (2011)
98. ^ a b c d e f g h i j k l Zomkowski AD, et al. Agmatine produces antidepressant-like effects in two models of depression in mice. Neuroreport. (2002)
99. ^ Ozaita A, et al. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver. Br J Pharmacol. (1997)
100. ^ a b Raasch W, Muhle H, Dominiak P. Modulation of MAO activity by imidazoline and guanidine derivatives. Ann N Y Acad Sci. (1999)
101. ^ Regunathan S, Meeley MP, Reis DJ. Expression of non-adrenergic imidazoline sites in chromaffin cells and mitochondrial membranes of bovine adrenal medulla. Biochem Pharmacol. (1993)
102. ^ Head GA, Mayorov DN. Imidazoline receptors, novel agents and therapeutic potential. Cardiovasc Hematol Agents Med Chem. (2006)
103. ^ a b c d e González C, et al. Agmatine, an endogenous modulator of noradrenergic neurotransmission in the rat tail artery. Br J Pharmacol. (1996)
104. ^ Molderings GJ, Göthert M. Inhibitory presynaptic imidazoline receptors on sympathetic nerves in the rabbit aorta differ from I1- and I2-imidazoline binding sites. Naunyn Schmiedebergs Arch Pharmacol. (1995)
105. ^ a b c d Askalany AR, et al. Effect of agmatine on heteromeric N-methyl-D-aspartate receptor channels. Neurosci Res. (2005)
106. ^ a b c d e f Yang XC, Reis DJ. Agmatine selectively blocks the N-methyl-D-aspartate subclass of glutamate receptor channels in rat hippocampal neurons. J Pharmacol Exp Ther. (1999)
107. ^ Reynolds IJ. Arcaine uncovers dual interactions of polyamines with the N-methyl-D-aspartate receptor. J Pharmacol Exp Ther. (1990)
108. ^ Anis N, et al. Structure-activity relationships of philanthotoxin analogs and polyamines on N-methyl-D-aspartate and nicotinic acetylcholine receptors. J Pharmacol Exp Ther. (1990)
109. ^ a b c d e f g Zhu MY, et al. Effect of agmatine against cell death induced by NMDA and glutamate in neurons and PC12 cells. Cell Mol Neurobiol. (2003)
110. ^ Brown RE, Stevens DR, Haas HL. The physiology of brain histamine. Prog Neurobiol. (2001)
111. ^ a b Burban A, et al. Histamine potentiates N-methyl-D-aspartate receptors by interacting with an allosteric site distinct from the polyamine binding site. J Pharmacol Exp Ther. (2010)
112. ^ Watanabe C, et al. Intrathecal high-dose histamine induces spinally-mediated nociceptive behavioral responses through a polyamine site of NMDA receptors. Eur J Pharmacol. (2008)
113. ^ a b c Wade CL, et al. Immunoneutralization of agmatine sensitizes mice to micro-opioid receptor tolerance. J Pharmacol Exp Ther. (2009)
114. ^ Lewis B, Wellmann KA, Barron S. Agmatine reduces balance deficits in a rat model of third trimester binge-like ethanol exposure. Pharmacol Biochem Behav. (2007)
115. ^ Barron S, et al. Polyamine modulation of NMDARs as a mechanism to reduce effects of alcohol dependence. Recent Pat CNS Drug Discov. (2012)
116. ^ a b Rawls SM, Gomez T, Raffa RB. An NMDA antagonist (LY 235959) attenuates abstinence-induced withdrawal of planarians following acute exposure to a cannabinoid agonist (WIN 55212-2). Pharmacol Biochem Behav. (2007)
117. ^ a b c d e f g h i Demady DR, et al. Agmatine enhances the NADPH oxidase activity of neuronal NO synthase and leads to oxidative inactivation of the enzyme. Mol Pharmacol. (2001)
118. ^ a b c Nishida CR, Ortiz de Montellano PR. Electron transfer and catalytic activity of nitric oxide synthases. Chimeric constructs of the neuronal, inducible, and endothelial isoforms. J Biol Chem. (1998)
119. ^ a b Abu-Soud HM, et al. Electron transfer in the nitric-oxide synthases. Characterization of L-arginine analogs that block heme iron reduction. J Biol Chem. (1994)
120. ^ Alagarsamy S, Johnson KM. Voltage-dependent calcium channel involvement in NMDA-induced activation of NOS. Neuroreport. (1995)
121. ^ a b Fairbanks CA, Wilcox GL. Acute tolerance to spinally administered morphine compares mechanistically with chronically induced morphine tolerance. J Pharmacol Exp Ther. (1997)
122. ^ Kolesnikov YA, et al. Blockade of tolerance to morphine but not to kappa opioids by a nitric oxide synthase inhibitor. Proc Natl Acad Sci U S A. (1993)
123. ^ a b Elliott K, et al. The NMDA receptor antagonists, LY274614 and MK-801, and the nitric oxide synthase inhibitor, NG-nitro-L-arginine, attenuate analgesic tolerance to the mu-opioid morphine but not to kappa opioids. Pain. (1994)
124. ^ a b Elliott K, et al. N-methyl-D-aspartate (NMDA) receptors, mu and kappa opioid tolerance, and perspectives on new analgesic drug development. Neuropsychopharmacology. (1995)
125. ^ Loring RH. Agmatine acts as an antagonist of neuronal nicotinic receptors. Br J Pharmacol. (1990)
126. ^ a b c d e f Krass M, et al. Antidepressant-like effect of agmatine is not mediated by serotonin. Behav Brain Res. (2008)
127. ^ Molderings GJ, et al. Inhibition of 5-HT3 receptor function by imidazolines in mouse neuroblastoma cells: potential involvement of sigma 2 binding sites. Naunyn Schmiedebergs Arch Pharmacol. (1996)
128. ^ a b c d e Taksande BG, et al. Antidepressant like effect of selective serotonin reuptake inhibitors involve modulation of imidazoline receptors by agmatine. Neuropharmacology. (2009)
129. ^ Kim HS, et al. NMDA receptor antagonists enhance 5-HT2 receptor-mediated behavior, head-twitch response, in PCPA-treated mice. Arch Pharm Res. (1999)
130. ^ Kim HS, Son YR, Kim SH. Nitric oxide synthase inhibitors enhance 5-HT2 receptor-mediated behavior, the head-twitch response in mice. Life Sci. (1999)
131. ^ a b Kotagale NR, et al. Evidences for the agmatine involvement in antidepressant like effect of bupropion in mouse forced swim test. Pharmacol Biochem Behav. (2013)
132. ^ a b Tsou K, et al. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience. (1998)
133. ^ a b Pettit DA, et al. Immunohistochemical localization of the neural cannabinoid receptor in rat brain. J Neurosci Res. (1998)
134. ^ a b Ruggiero DA, et al. Immunocytochemical localization of an imidazoline receptor protein in the central nervous system. Brain Res. (1998)
135. ^ a b Molderings GJ, Likungu J, Göthert M. Presynaptic cannabinoid and imidazoline receptors in the human heart and their potential relationship. Naunyn Schmiedebergs Arch Pharmacol. (1999)
136. ^ a b c d e f g Aggarwal S, et al. Agmatine enhances cannabinoid action in the hot-plate assay of thermal nociception. Pharmacol Biochem Behav. (2009)
137. ^ a b Rawls SM, Tallarida RJ, Zisk J. Agmatine and a cannabinoid agonist, WIN 55212-2, interact to produce a hypothermic synergy. Eur J Pharmacol. (2006)
138. ^ a b Compton DR, et al. Aminoalkylindole analogs: cannabimimetic activity of a class of compounds structurally distinct from delta 9-tetrahydrocannabinol. J Pharmacol Exp Ther. (1992)
139. ^ a b c Thorat SN, Bhargava HN. Effects of NMDA receptor blockade and nitric oxide synthase inhibition on the acute and chronic actions of delta 9-tetrahydrocannabinol in mice. Brain Res. (1994)
140. ^ a b Spina E, et al. A role of nitric oxide in WIN 55,212-2 tolerance in mice. Eur J Pharmacol. (1998)
141. ^ a b Molderings GJ, et al. Presynaptic imidazoline receptors and non-adrenoceptor {3H}-idazoxan binding sites in human cardiovascular tissues. Br J Pharmacol. (1997)
142. ^ Wong CS, et al. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors. Eur J Pharmacol. (1996)
143. ^ a b Li J, et al. Effects of agmatine on tolerance to and substance dependence on morphine in mice. Zhongguo Yao Li Xue Bao. (1999)
144. ^ a b Kolesnikov Y, Jain S, Pasternak GW. Modulation of opioid analgesia by agmatine. Eur J Pharmacol. (1996)
145. ^ Yeşilyurt O, Uzbay IT. Agmatine potentiates the analgesic effect of morphine by an alpha(2)-adrenoceptor-mediated mechanism in mice. Neuropsychopharmacology. (2001)
146. ^ Bhalla S, Rapolaviciute V, Gulati A. Determination of α(2)-adrenoceptor and imidazoline receptor involvement in augmentation of morphine and oxycodone analgesia by agmatine and BMS182874. Eur J Pharmacol. (2011)
147. ^ Su RB, et al. Effects of intragastric agmatine on morphine-induced physiological dependence in beagle dogs and rhesus monkeys. Eur J Pharmacol. (2008)
148. ^ Gold MS, Redmond DE Jr, Kleber HD. Clonidine blocks acute opiate-withdrawal symptoms. Lancet. (1978)
149. ^ Kosten TA. Clonidine attenuates conditioned aversion produced by naloxone-precipitated opiate withdrawal. Eur J Pharmacol. (1994)
150. ^ Maldonado R. Participation of noradrenergic pathways in the expression of opiate withdrawal: biochemical and pharmacological evidence. Neurosci Biobehav Rev. (1997)
151. ^ Iglesias V, et al. Effects of yohimbine on morphine analgesia and physical dependence in the rat. Eur J Pharmacol. (1992)
152. ^ Dwoskin LP, Neal BS, Sparber SB. Yohimbine exacerbates and clonidine attenuates acute morphine withdrawal in rats. Eur J Pharmacol. (1983)
153. ^ Wade CL, et al. Supraspinally-administered agmatine attenuates the development of oral fentanyl self-administration. Eur J Pharmacol. (2008)
154. ^ a b Morgan AD, et al. Effects of agmatine on the escalation of intravenous cocaine and fentanyl self-administration in rats. Pharmacol Biochem Behav. (2002)
155. ^ Huston JP, et al. What’s conditioned in conditioned place preference. Trends Pharmacol Sci. (2013)
156. ^ Tahsili-Fahadan P, et al. Agmatine potentiates morphine-induced conditioned place preference in mice: modulation by alpha2-adrenoceptors. Neuropsychopharmacology. (2006)
157. ^ a b Yu Y, et al. A nonproton ligand sensor in the acid-sensing ion channel. Neuron. (2010)
158. ^ a b c d Li WG, et al. ASIC3 channels integrate agmatine and multiple inflammatory signals through the nonproton ligand sensing domain. Mol Pain. (2010)
159. ^ a b Wemmie JA, Price MP, Welsh MJ. Acid-sensing ion channels: advances, questions and therapeutic opportunities. Trends Neurosci. (2006)
160. ^ Waldmann R, et al. A proton-gated cation channel involved in acid-sensing. Nature. (1997)
161. ^ de Weille JR, et al. Identification, functional expression and chromosomal localisation of a sustained human proton-gated cation channel. FEBS Lett. (1998)
162. ^ Salinas M, Lazdunski M, Lingueglia E. Structural elements for the generation of sustained currents by the acid pain sensor ASIC3. J Biol Chem. (2009)
163. ^ Deval E, et al. ASIC3, a sensor of acidic and primary inflammatory pain. EMBO J. (2008)
164. ^ Li WG, Xu TL. ASIC3 channels in multimodal sensory perception. ACS Chem Neurosci. (2011)
165. ^ Zhang M, Wang H, Tracey KJ. Regulation of macrophage activation and inflammation by spermine: a new chapter in an old story. Crit Care Med. (2000)
166. ^ Fairbanks CA, et al. Agmatine reverses pain induced by inflammation, neuropathy, and spinal cord injury. Proc Natl Acad Sci U S A. (2000)
167. ^ Su RB, Li J, Qin BY. A biphasic opioid function modulator: agmatine. Acta Pharmacol Sin. (2003)
168. ^ a b c Keynan O, et al. Safety and Efficacy of Dietary Agmatine Sulfate in Lumbar Disc-associated Radiculopathy. An Open-label, Dose-escalating Study Followed by a Randomized, Double-blind, Placebo-controlled Trial. Pain Med. (2010)
169. ^ Buchhalter AR, Fant RV, Henningfield JE. Novel pharmacological approaches for treating tobacco dependence and withdrawal: current status. Drugs. (2008)
170. ^ Gourlay S, et al. A placebo-controlled study of three clonidine doses for smoking cessation. Clin Pharmacol Ther. (1994)
171. ^ Yamanaka K, Oshita M, Muramatsu I. Alteration of alpha and muscarinic receptors in rat brain and heart following chronic nicotine treatment. Brain Res. (1985)
172. ^ a b Kotagale NR, et al. Repeated agmatine treatment attenuates nicotine sensitization in mice: modulation by alpha2-adrenoceptors. Behav Brain Res. (2010)
173. ^ Zaniewska M, et al. Effects of agmatine on nicotine-evoked behavioral responses in rats. Pharmacol Rep. (2008)
174. ^ Uzbay IT, et al. Effects of agmatine on ethanol withdrawal syndrome in rats. Behav Brain Res. (2000)
175. ^ a b c d e Taksande BG, et al. Agmatine, an endogenous imidazoline receptor ligand modulates ethanol anxiolysis and withdrawal anxiety in rats. Eur J Pharmacol. (2010)
176. ^ Littleton JM, et al. Role of polyamines and NMDA receptors in ethanol dependence and withdrawal. Alcohol Clin Exp Res. (2001)
177. ^ Gibson DA, et al. Polyamines contribute to ethanol withdrawal-induced neurotoxicity in rat hippocampal slice cultures through interactions with the NMDA receptor. Alcohol Clin Exp Res. (2003)
178. ^ Collins ED, et al. The effects of memantine on the subjective, reinforcing and cardiovascular effects of cocaine in humans. Behav Pharmacol. (1998)
179. ^ Collins ED, et al. The effects of acute pretreatment with high-dose memantine on the cardiovascular and behavioral effects of cocaine in humans. Exp Clin Psychopharmacol. (2007)
180. ^ Rawls SM, et al. A nitric oxide synthase inhibitor (L-NAME) attenuates abstinence-induced withdrawal from both cocaine and a cannabinoid agonist (WIN 55212-2) in Planaria. Brain Res. (2006)
181. ^ a b Cantin L, et al. Cocaine is low on the value ladder of rats: possible evidence for resilience to addiction. PLoS One. (2010)
182. ^ Lenoir M, et al. Intense sweetness surpasses cocaine reward. PLoS One. (2007)
183. ^ a b c d Wang CC, et al. Beneficial effect of agmatine on brain apoptosis, astrogliosis, and edema after rat transient cerebral ischemia. BMC Pharmacol. (2010)
184. ^ a b Agmatine reduced the expressions of nitric oxide synthase and peroxynitrite formation in rat cerebral cortex after transient global cerebral ischemia.
185. ^ a b c Kim JH, et al. Agmatine attenuates brain edema through reducing the expression of aquaporin-1 after cerebral ischemia. J Cereb Blood Flow Metab. (2010)
186. ^ a b c Lee WT, et al. Neuroprotective effects of agmatine on oxygen-glucose deprived primary-cultured astrocytes and nuclear translocation of nuclear factor-kappa B. Brain Res. (2009)
187. ^ Kim JH, et al. Agmatine reduces infarct area in a mouse model of transient focal cerebral ischemia and protects cultured neurons from ischemia-like injury. Exp Neurol. (2004)
188. ^ a b c Feng Y, Piletz JE, Leblanc MH. Agmatine suppresses nitric oxide production and attenuates hypoxic-ischemic brain injury in neonatal rats. Pediatr Res. (2002)
189. ^ Iadecola C. Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci. (1997)
190. ^ Moro MA, et al. Role of nitric oxide after brain ischaemia. Cell Calcium. (2004)
191. ^ Raghavan SA, Dikshit M. Vascular regulation by the L-arginine metabolites, nitric oxide and agmatine. Pharmacol Res. (2004)
192. ^ Huang Z, et al. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science. (1994)
193. ^ Mun CH, et al. Regulation of endothelial nitric oxide synthase by agmatine after transient global cerebral ischemia in rat brain. Anat Cell Biol. (2010)
194. ^ Ma T, et al. Generation and phenotype of a transgenic knockout mouse lacking the mercurial-insensitive water channel aquaporin-4. J Clin Invest. (1997)
195. ^ Manley GT, et al. Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke. Nat Med. (2000)
196. ^ Ribeiro Mde C, et al. Time course of aquaporin expression after transient focal cerebral ischemia in mice. J Neurosci Res. (2006)
197. ^ Gilad GM, et al. Agmatine treatment is neuroprotective in rodent brain injury models. Life Sci. (1996)
198. ^ Panet H, et al. Activation of nuclear transcription factor kappa B (NF-kappaB) is essential for dopamine-induced apoptosis in PC12 cells. J Neurochem. (2001)
199. ^ a b Seo SK, et al. Overexpression of human arginine decarboxylase rescues human mesenchymal stem cells against H₂O₂ toxicity through cell survival protein activation. J Korean Med Sci. (2013)
200. ^ a b c Santhanam AV, Viswanathan S, Dikshit M. Activation of protein kinase B/Akt and endothelial nitric oxide synthase mediates agmatine-induced endothelium-dependent relaxation. Eur J Pharmacol. (2007)
201. ^ Li W, et al. An essential role for the Id1/PI3K/Akt/NFkB/survivin signalling pathway in promoting the proliferation of endothelial progenitor cells in vitro. Mol Cell Biochem. (2012)
202. ^ Kanwar JR, Kamalapuram SK, Kanwar RK. Targeting survivin in cancer: the cell-signalling perspective. Drug Discov Today. (2011)
203. ^ Lin J, et al. Inhibitor of differentiation 1 contributes to head and neck squamous cell carcinoma survival via the NF-kappaB/survivin and phosphoinositide 3-kinase/Akt signaling pathways. Clin Cancer Res. (2010)
204. ^ Young ND, Galston AW. Putrescine and Acid Stress : Induction of Arginine Decarboxylase Activity and Putrescine Accumulation by Low pH. Plant Physiol. (1983)
205. ^ Bliven KA, Fisher DJ, Maurelli AT. Characterization of the activity and expression of arginine decarboxylase in human and animal Chlamydia pathogens. FEMS Microbiol Lett. (2012)
206. ^ Pothipongsa A, Jantaro S, Incharoensakdi A. Polyamines induced by osmotic stress protect Synechocystis sp. PCC 6803 cells and arginine decarboxylase transcripts against UV-B radiation. Appl Biochem Biotechnol. (2012)
207. ^ Xu X, Shi G, Jia R. Changes of polyamine levels in roots of Sagittaria sagittifolia L. under copper stress. Environ Sci Pollut Res Int. (2011)
208. ^ a b Ruiz-Durántez E, et al. Effect of agmatine on locus coeruleus neuron activity: possible involvement of nitric oxide. Br J Pharmacol. (2002)
209. ^ Weiss JM, et al. Depression and anxiety: role of the locus coeruleus and corticotropin-releasing factor. Brain Res Bull. (1994)
210. ^ a b Lavinsky D, Arteni NS, Netto CA. Agmatine induces anxiolysis in the elevated plus maze task in adult rats. Behav Brain Res. (2003)
211. ^ a b c d e Aricioglu F, Altunbas H. Is agmatine an endogenous anxiolytic/antidepressant agent. Ann N Y Acad Sci. (2003)
212. ^ a b Gong ZH, et al. Anxiolytic effect of agmatine in rats and mice. Eur J Pharmacol. (2006)
213. ^ Halaris A, Piletz JE. Relevance of imidazoline receptors and agmatine to psychiatry: a decade of progress. Ann N Y Acad Sci. (2003)
214. ^ Kaster MP, et al. Effects of potassium channel inhibitors in the forced swimming test: possible involvement of L-arginine-nitric oxide-soluble guanylate cyclase pathway. Behav Brain Res. (2005)
215. ^ Zomkowski AD, Santos AR, Rodrigues AL. Evidence for the involvement of the opioid system in the agmatine antidepressant-like effect in the forced swimming test. Neurosci Lett. (2005)
216. ^ a b c d Budni J, et al. Role of different types of potassium channels in the antidepressant-like effect of agmatine in the mouse forced swimming test. Eur J Pharmacol. (2007)
217. ^ Fluoxetine inhibits A-type potassium currents in primary cultured rat hippocampal neurons.
218. ^ Differential blockade of neuronal voltage-gated Na+ and K+ channels by antidepressant drugs.
219. ^ Inhibition of G Protein-Activated Inwardly Rectifying K+ Channels by Phencyclidine.
220. ^ Kobayashi T, Washiyama K, Ikeda K. Inhibition of G protein-activated inwardly rectifying K+ channels by various antidepressant drugs. Neuropsychopharmacology. (2004)
221. ^ Kaster MP, et al. The inhibition of different types of potassium channels underlies the antidepressant-like effect of adenosine in the mouse forced swimming test. Prog Neuropsychopharmacol Biol Psychiatry. (2007)
222. ^ Budni J, et al. Role of potassium channels in the antidepressant-like effect of folic acid in the forced swimming test in mice. Pharmacol Biochem Behav. (2012)
223. ^ Redrobe JP, Pinot P, Bourin M. The effect of the potassium channel activator, cromakalim, on antidepressant drugs in the forced swimming test in mice. Fundam Clin Pharmacol. (1996)
224. ^ Bortolatto CF, et al. Involvement of potassium channels in the antidepressant-like effect of venlafaxine in mice. Life Sci. (2010)
225. ^ Kelly JS, et al. Serotonin receptor heterogeneity and the role of potassium channels in neuronal excitability. Adv Exp Med Biol. (1991)
226. ^ a b c Weng XC, et al. Agmatine blocked voltage-gated calcium channel in cultured rat hippocampal neurons. Acta Pharmacol Sin. (2003)
227. ^ a b The clinical antidepressant effect of exogenous agmatine is not reversed by parachlorophenylalanine: a pilot study.
228. ^ Pedrazzini T, Pralong F, Grouzmann E. Neuropeptide Y: the universal soldier. Cell Mol Life Sci. (2003)
229. ^ Kask A, Rägo L, Harro J. Evidence for involvement of neuropeptide Y receptors in the regulation of food intake: studies with Y1-selective antagonist BIBP3226. Br J Pharmacol. (1998)
230. ^ Huguet F, et al. Age-related changes of noradrenergic-NPY interaction in rat brain: norepinephrine, NPY levels and alpha-adrenoceptors. Brain Res. (1993)
231. ^ Sawchenko PE, et al. Colocalization of neuropeptide Y immunoreactivity in brainstem catecholaminergic neurons that project to the paraventricular nucleus of the hypothalamus. J Comp Neurol. (1985)
232. ^ Everitt BJ, et al. Differential co-existence of neuropeptide Y (NPY)-like immunoreactivity with catecholamines in the central nervous system of the rat. Neuroscience. (1984)
233. ^ Franco-Cereceda A, et al. Differential effects of clonidine and reserpine treatment on neuropeptide Y content in some sympathetically innervated tissues of the guinea-pig. Eur J Pharmacol. (1987)
234. ^ Smiałowska M, et al. Clonidine administration increases neuropeptide Y immunoreactivity and neuropeptide Y mRNA in the rat cerebral cortex neurons. Neuropeptides. (1997)
235. ^ Clark JT, et al. Alpha 2-adrenoceptor blockade attenuates feeding behavior induced by neuropeptide Y and epinephrine. Physiol Behav. (1988)
236. ^ Heilig M, Wahlestedt C, Widerlöv E. Neuropeptide Y (NPY)-induced suppression of activity in the rat: evidence for NPY receptor heterogeneity and for interaction with alpha-adrenoceptors. Eur J Pharmacol. (1988)
237. ^ Prasad A, Prasad C. Agmatine enhances caloric intake and dietary carbohydrate preference in satiated rats. Physiol Behav. (1996)
238. ^ a b Seo S, Liu P, Leitch B. Spatial learning-induced accumulation of agmatine and glutamate at hippocampal CA1 synaptic terminals. Neuroscience. (2011)
239. ^ a b Betancourt L, et al. In vivo monitoring of cerebral agmatine by microdialysis and capillary electrophoresis. J Chromatogr B Analyt Technol Biomed Life Sci. (2012)
240. ^ a b Liu P, et al. Spatial learning results in elevated agmatine levels in the rat brain. Hippocampus. (2008)
241. ^ Leitch B, et al. Spatial learning-induced increase in agmatine levels at hippocampal CA1 synapses. Synapse. (2011)
242. ^ a b c Rushaidhi M, et al. Participation of hippocampal agmatine in spatial learning: an in vivo microdialysis study. Neuropharmacology. (2013)
243. ^ Wang ZM, et al. Effects of agmatine on neuronal discharges in rat hippocampal CA1 area. Sheng Li Xue Bao. (2003)
244. ^ a b Liu P, et al. Memory-related changes in L-citrulline and agmatine in the rat brain. Hippocampus. (2009)
245. ^ a b c d Arteni NS, et al. Agmatine facilitates memory of an inhibitory avoidance task in adult rats. Neurobiol Learn Mem. (2002)
246. ^ a b Zhou HC, et al. Activation of β2-adrenoceptor enhances synaptic potentiation and behavioral memory via cAMP-PKA signaling in the medial prefrontal cortex of rats. Learn Mem. (2013)
247. ^ a b Dalley JW, Cardinal RN, Robbins TW. Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates. Neurosci Biobehav Rev. (2004)
248. ^ a b Gaffan D, Parker A. Interaction of perirhinal cortex with the fornix-fimbria: memory for objects and “object-in-place” memory. J Neurosci. (1996)
249. ^ Riccio A, et al. Mediation by a CREB family transcription factor of NGF-dependent survival of sympathetic neurons. Science. (1999)
250. ^ Du K, Montminy M. CREB is a regulatory target for the protein kinase Akt/PKB. J Biol Chem. (1998)
251. ^ Chen X, et al. Ischemic rat brain extracts induce human marrow stromal cell growth factor production. Neuropathology. (2002)
252. ^ Lu Y, Christian K, Lu B. BDNF: a key regulator for protein synthesis-dependent LTP and long-term memory. Neurobiol Learn Mem. (2008)
253. ^ Collingridge GL, Bliss TV. Memories of NMDA receptors and LTP. Trends Neurosci. (1995)
254. ^ Cain DP. LTP, NMDA, genes and learning. Curr Opin Neurobiol. (1997)
255. ^ Hawkins RD, Son H, Arancio O. Nitric oxide as a retrograde messenger during long-term potentiation in hippocampus. Prog Brain Res. (1998)
256. ^ Yananli H, et al. Effect of agmatine on brain L-citrulline production during morphine withdrawal in rats: a microdialysis study in nucleus accumbens. Brain Res. (2007)
257. ^ Rastegar K, et al. The Effect of Intra-CA1 Agmatine Microinjection on Water Maze Learning and Memory in Rat. Iran Red Crescent Med J. (2011)
258. ^ a b Stewart LS, McKay BE. Acquisition deficit and time-dependent retrograde amnesia for contextual fear conditioning in agmatine-treated rats. Behav Pharmacol. (2000)
259. ^ a b McKay BE, et al. Learning and memory in agmatine-treated rats. Pharmacol Biochem Behav. (2002)
260. ^ a b c d Rushaidhi M, et al. Agmatine selectively improves behavioural function in aged male Sprague-Dawley rats. Neuroscience. (2012)
261. ^ a b c Liu P, et al. Behavioral effects of intracerebroventricular microinfusion of agmatine in adult rats. Behav Neurosci. (2008)
262. ^ Liu P, Collie ND. Behavioral effects of agmatine in naive rats are task- and delay-dependent. Neuroscience. (2009)
263. ^ Szabó C. Physiological and pathophysiological roles of nitric oxide in the central nervous system. Brain Res Bull. (1996)
264. ^ a b c Demehri S, et al. Agmatine exerts anticonvulsant effect in mice: modulation by alpha 2-adrenoceptors and nitric oxide. Neuropharmacology. (2003)
265. ^ a b c Bence AK, et al. An in vivo evaluation of the antiseizure activity and acute neurotoxicity of agmatine. Pharmacol Biochem Behav. (2003)
266. ^ a b Luszczki JJ, et al. Agmatine enhances the anticonvulsant action of phenobarbital and valproate in the mouse maximal electroshock seizure model. J Neural Transm. (2008)
267. ^ Anticonvulsive effect of agmatine in mice.
268. ^ Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum.
269. ^ Garthwaite J, Charles SL, Chess-Williams R. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature. (1988)
270. ^ Schoemaker H. Polyamines allosterically modulate {3H}nitrendipine binding to the voltage-sensitive calcium channel in rat brain. Eur J Pharmacol. (1992)
271. ^ Jeong SY, et al. Nitric oxide directly activates large conductance Ca2+-activated K+ channels (rSlo). Mol Cells. (2001)
272. ^ Shin JH, et al. Nitric oxide directly activates calcium-activated potassium channels from rat brain reconstituted into planar lipid bilayer. FEBS Lett. (1997)
273. ^ Denninger JW, Marletta MA. Guanylate cyclase and the .NO/cGMP signaling pathway. Biochim Biophys Acta. (1999)
274. ^ a b Bhutada P, et al. Agmatine, an endogenous ligand of imidazoline receptor protects against memory impairment and biochemical alterations in streptozotocin-induced diabetic rats. Prog Neuropsychopharmacol Biol Psychiatry. (2012)
275. ^ a b c d e f g Hwang SL, et al. Activation of imidazoline receptors in adrenal gland to lower plasma glucose in streptozotocin-induced diabetic rats. Diabetologia. (2005)
276. ^ Bergin DH, Liu P. Agmatine protects against beta-amyloid25-35-induced memory impairments in the rat. Neuroscience. (2010)
277. ^ Matheus FC, et al. Neuroprotective effects of agmatine in mice infused with a single intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Behav Brain Res. (2012)
278. ^ Moosavi M, et al. Agmatine protects against scopolamine-induced water maze performance impairment and hippocampal ERK and Akt inactivation. Neuropharmacology. (2012)
279. ^ Utkan T, et al. Agmatine, a metabolite of L-arginine, reverses scopolamine-induced learning and memory impairment in rats. Pharmacol Biochem Behav. (2012)
280. ^ Zarifkar A, et al. Agmatine prevents LPS-induced spatial memory impairment and hippocampal apoptosis. Eur J Pharmacol. (2010)
281. ^ Ahn SK, et al. Protective effects of agmatine on lipopolysaccharide-injured microglia and inducible nitric oxide synthase activity. Life Sci. (2012)
282. ^ a b Kohl S, et al. Prepulse inhibition in psychiatric disorders–apart from schizophrenia. J Psychiatr Res. (2013)
283. ^ Geyer MA, et al. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology (Berl). (2001)
284. ^ Giakoumaki SG. Cognitive and prepulse inhibition deficits in psychometrically high schizotypal subjects in the general population: relevance to schizophrenia research. J Int Neuropsychol Soc. (2012)
285. ^ a b Uzbay T, et al. Agmatine disrupts prepulse inhibition of acoustic startle reflex in rats. J Psychopharmacol. (2010)
286. ^ Pålsson E, et al. Agmatine attenuates the disruptive effects of phencyclidine on prepulse inhibition. Eur J Pharmacol. (2008)
287. ^ Kotagale NR, et al. Psychopharmacological study of agmatine in behavioral tests of schizophrenia in rodents. Pharmacol Biochem Behav. (2012)
288. ^ Liu P, et al. Age-related changes in nitric oxide synthase and arginase in the rat prefrontal cortex. Neurobiol Aging. (2004)
289. ^ Liu P, et al. Effects of aging on agmatine levels in memory-associated brain structures. Hippocampus. (2008)
290. ^ Liu P, et al. Age-related changes in polyamines in memory-associated brain structures in rats. Neuroscience. (2008)
291. ^ Gupta N, et al. Ageing alters behavioural function and brain arginine metabolism in male Sprague-Dawley rats. Neuroscience. (2012)
292. ^ Liu P, et al. Potential involvement of NOS and arginase in age-related behavioural impairments. Exp Gerontol. (2004)
293. ^ Liu P, et al. Hippocampal nitric oxide synthase and arginase and age-associated behavioral deficits. Hippocampus. (2005)
294. ^ Rushaidhi M, Zhang H, Liu P. Effects of prolonged agmatine treatment in aged male Sprague-Dawley rats. Neuroscience. (2013)
295. ^ a b c d e f Joshi MS, et al. Receptor-mediated activation of nitric oxide synthesis by arginine in endothelial cells. Proc Natl Acad Sci U S A. (2007)
296. ^ a b Haulică I, et al. Preliminary research on possible relationship of NO with agmatine at the vascular level. Rom J Physiol. (1999)
297. ^ a b c d e Schwartz D, et al. Agmatine affects glomerular filtration via a nitric oxide synthase-dependent mechanism. Am J Physiol. (1997)
298. ^ Fill M, Copello JA. Ryanodine receptor calcium release channels. Physiol Rev. (2002)
299. ^ Nitric Oxide-induced Mobilization of Intracellular Calcium via the Cyclic ADP-ribose Signaling Pathway.
300. ^ Stoyanovsky D, et al. Nitric oxide activates skeletal and cardiac ryanodine receptors. Cell Calcium. (1997)
301. ^ Galione A, Lee HC, Busa WB. Ca(2+)-induced Ca2+ release in sea urchin egg homogenates: modulation by cyclic ADP-ribose. Science. (1991)
302. ^ Lee HC, Galione A, Walseth TF. Cyclic ADP-ribose: metabolism and calcium mobilizing function. Vitam Horm. (1994)
303. ^ a b c d e Satriano J, et al. Effects on kidney filtration rate by agmatine requires activation of ryanodine channels for nitric oxide generation. Am J Physiol Renal Physiol. (2008)
304. ^ Jagnandan D, Sessa WC, Fulton D. Intracellular location regulates calcium-calmodulin-dependent activation of organelle-restricted eNOS. Am J Physiol Cell Physiol. (2005)
305. ^ Liou SF, et al. The vasorelaxing action of labedipinedilol-A involves endothelial cell-derived NO and eNOS expression caused by calcium influx. J Cardiovasc Pharmacol. (2005)
306. ^ eNOS at a glance.
307. ^ Kakizawa S, Yamazawa T, Iino M. Nitric oxide-induced calcium release: activation of type 1 ryanodine receptor by endogenous nitric oxide. Channels (Austin). (2013)
308. ^ Chen CT, et al. Activation of imidazoline I-2B receptor by metformin to increase glucose uptake in skeletal muscle. Horm Metab Res. (2011)
309. ^ Yamboliev IA, Mutafova-Yambolieva VN. PI3K and PKC contribute to membrane depolarization mediated by alpha2-adrenoceptors in the canine isolated mesenteric vein. BMC Physiol. (2005)
310. ^ Lu XL, et al. Marine cyclotripeptide X-13 promotes angiogenesis in zebrafish and human endothelial cells via PI3K/Akt/eNOS signaling pathways. Mar Drugs. (2012)
311. ^ Shi F, et al. Effects of simulated microgravity on human umbilical vein endothelial cell angiogenesis and role of the PI3K-Akt-eNOS signal pathway. PLoS One. (2012)
312. ^ Jung HJ, et al. Agmatine promotes the migration of murine brain endothelial cells via multiple signaling pathways. Life Sci. (2013)
313. ^ a b Auguet M, et al. Selective inhibition of inducible nitric oxide synthase by agmatine. Jpn J Pharmacol. (1995)
314. ^ Jianmongkol S, et al. Aminoguanidine-mediated inactivation and alteration of neuronal nitric-oxide synthase. J Biol Chem. (2000)
315. ^ Wolff DJ, Lubeskie A. Aminoguanidine is an isoform-selective, mechanism-based inactivator of nitric oxide synthase. Arch Biochem Biophys. (1995)
316. ^ Nakatsuka M, Nakatsuka K, Osawa Y. Metabolism-based inactivation of penile nitric oxide synthase activity by guanabenz. Drug Metab Dispos. (1998)
317. ^ Li Q, et al. Effect of agmatine on intracellular free calcium concentration in isolated rat ventricular myocytes. Sheng Li Xue Bao. (2002)
318. ^ Li Q, Yin JX, He RR. Effect of agmatine on L-type calcium current in rat ventricular myocytes. Acta Pharmacol Sin. (2002)
319. ^ a b c d Lortie MJ, et al. Agmatine, a bioactive metabolite of arginine. Production, degradation, and functional effects in the kidney of the rat. J Clin Invest. (1996)
320. ^ Gao Y, et al. Agmatine: a novel endogenous vasodilator substance. Life Sci. (1995)
321. ^ Ishikawa T, et al. N omega-hydroxyagmatine: a novel substance causing endothelium-dependent vasorelaxation. Biochem Biophys Res Commun. (1995)
322. ^ Gill F, et al. Effects of agmatine on the survival rate in rats bled to hemorrhage. Arzneimittelforschung. (2011)
323. ^ Ernsberger P, et al. Hypotensive action of clonidine analogues correlates with binding affinity at imidazole and not alpha-2-adrenergic receptors in the rostral ventrolateral medulla. J Hypertens Suppl. (1988)
324. ^ Ernsberger P, et al. Role of imidazole receptors in the vasodepressor response to clonidine analogs in the rostral ventrolateral medulla. J Pharmacol Exp Ther. (1990)
325. ^ Jou SB, Liu IM, Cheng JT. Activation of imidazoline receptor by agmatine to lower plasma glucose in streptozotocin-induced diabetic rats. Neurosci Lett. (2004)
326. ^ Schäfer U, et al. Effects of agmatine on the cardiovascular system of spontaneously hypertensive rats. Ann N Y Acad Sci. (1999)
327. ^ Sun MK, Regunathan S, Reis DJ. Cardiovascular responses to agmatine, a clonidine-displacing substance, in anesthetized rat. Clin Exp Hypertens. (1995)
328. ^ Khan S, et al. Beta-endorphin decreases fatigue and increases glucose uptake independently in normal and dystrophic mice. Muscle Nerve. (2005)
329. ^ Cheng JT, et al. Plasma glucose-lowering effect of beta-endorphin in streptozotocin-induced diabetic rats. Horm Metab Res. (2002)
330. ^ a b Evans AA, Khan S, Smith ME. Evidence for a hormonal action of beta-endorphin to increase glucose uptake in resting and contracting skeletal muscle. J Endocrinol. (1997)
331. ^ Radosevich PM, et al. Beta-endorphin inhibits glucose production in the conscious dog. J Clin Invest. (1984)
332. ^ Curry DL, Bennett LL, Li CH. Stimulation of insulin secretion by beta-endorphins (1-27 & 1-31). Life Sci. (1987)
333. ^ Hauner H, et al. Endogenous opiates do not influence glucose and lipid metabolism in rat adipocytes. Exp Clin Endocrinol. (1988)
334. ^ Kalra SP, et al. Agmatine, a novel hypothalamic amine, stimulates pituitary luteinizing hormone release in vivo and hypothalamic luteinizing hormone-releasing hormone release in vitro. Neurosci Lett. (1995)
335. ^ Hong S, et al. Agmatine protects retinal ganglion cells from hypoxia-induced apoptosis in transformed rat retinal ganglion cell line. BMC Neurosci. (2007)
336. ^ Hong S, et al. Ocular hypotensive effects of topically administered agmatine in a chronic ocular hypertensive rat model. Exp Eye Res. (2010)
337. ^ Hong S, et al. Retinal protective effects of topically administered agmatine on ischemic ocular injury caused by transient occlusion of the ophthalmic artery. Braz J Med Biol Res. (2012)
338. ^ Al Masri AA, El Eter E. Agmatine induces gastric protection against ischemic injury by reducing vascular permeability in rats. World J Gastroenterol. (2012)
339. ^ a b Utkan T, et al. Investigation on the mechanism involved in the effects of agmatine on ethanol-induced gastric mucosal injury in rats. Life Sci. (2000)
340. ^ Glavin GB, Smyth DD. Effects of the selective I1 imidazoline receptor agonist, moxonidine, on gastric secretion and gastric mucosal injury in rats. Br J Pharmacol. (1995)
341. ^ Glavin GB, Carlisle MA, Smyth DD. Agmatine, an endogenous imidazoline receptor agonist, increases gastric secretion and worsens experimental gastric mucosal injury in rats. J Pharmacol Exp Ther. (1995)
342. ^ Zádori ZS, et al. Imidazoline versus alpha2-adrenoceptors in the control of gastric motility in mice. Eur J Pharmacol. (2013)
343. ^ Molderings GJ, et al. Potential relevance of agmatine as a virulence factor of Helicobacter pylori. Dig Dis Sci. (1999)
344. ^ Bidet M, et al. Video microscopy of intracellular pH in primary cultures of rabbit proximal and early distal tubules. Pflugers Arch. (1990)
345. ^ a b Jurkiewicz NH, et al. Functional properties of agmatine in rat vas deferens. Eur J Pharmacol. (1996)
346. ^ a b Santos WC, et al. Dual effect of agmatine in the bisected rat vas deferens. J Pharm Pharmacol. (2003)
347. ^ Presta A, et al. Substrate binding and calmodulin binding to endothelial nitric oxide synthase coregulate its enzymatic activity. Nitric Oxide. (1997)
348. ^ Aglawe MM, et al. Participation of central imidazoline binding sites in antinociceptive effect of ethanol and nicotine in rats. Fundam Clin Pharmacol. (2013)
349. ^ Ozden O, et al. Agmatine blocks ethanol-induced locomotor hyperactivity in male mice. Eur J Pharmacol. (2011)
350. ^ Sameer SM, Chakraborty SS, Ugale RR. Agmatine attenuates acquisition but not the expression of ethanol conditioned place preference in mice: a role for imidazoline receptors. Behav Pharmacol. (2013)
351. ^ Uzbay T, et al. Sex-related effects of agmatine on caffeine-induced locomotor activity in Swiss Webster mice. Eur J Pharmacol. (2010)
352. ^ MATERIAL SAFETY DATA SHEET Agmatine.